Which GLP-1s does Ambetter cover? 4 checked
Ambetter publishes a policy on 4 GLP-1s we track. Of those, 2 are covered with prior approval and 2 depend on your plan. Each answer below names the conditions it covers and cites the document it came from.
Does Ambetter cover Wegovy and Zepbound?
Yes for cardiovascular risk reduction (wegovy, select indication), metabolic dysfunction-associated steatohepatitis (wegovy injection), obstructive sleep apnea (zepbound, surmount-osa indication), obesity / chronic weight management (california, ambetter from health net), obstructive sleep apnea (california, ambetter from health net) and formulary placement on the 2026 ambetter state drug lists. No for obesity / chronic weight management (wegovy) and obesity / chronic weight management (zepbound).
Not for weight loss in most states, and yes for a short list of other diagnoses. Wegovy for weight management is "a benefit exclusion and will not be authorized." Zepbound for weight management carries the identical sentence. Both Centene marketplace policies do authorize Wegovy for cardiovascular risk reduction and for MASH with moderate to advanced liver fibrosis, and Zepbound for moderate to severe sleep apnea, each with prior authorization. California is the exception. Ambetter there is sold as Ambetter from Health Net, its drug list says most plans do cover weight-loss medications after prior authorization, and the governing criteria set a marketplace threshold of BMI 40 or higher.
Source: Ambetter from Sunshine Health 2026 Formulary, effective January 1 2026, document code AMB25-FL-C-00023, formulary introduction and the ADHD/anti-narcolepsy/anti-obesity/anorexiants section. Read August 15, 2026.
The full Ambetter policy on Wegovy and Zepbound has the BMI bar, the step-therapy rule and what happens at renewal.
Does Ambetter cover Ozempic?
Yes, with prior approval. Ambetter pays for Ozempic once your prescriber gets the plan to sign off.
Ambetter marketplace plans cover Ozempic for type 2 diabetes, but only with prior authorization. Ozempic sits on Ambetter's preferred GLP-1 list, so the plan asks for a documented type 2 diabetes diagnosis, age 18 or older, no overlap with another GLP-1, and a dose within the FDA-approved maximum. Ambetter will not cover Ozempic for weight loss, because Ozempic is FDA-approved for type 2 diabetes only. Wegovy is the weight-loss semaglutide, and most Ambetter marketplace plans exclude weight-loss GLP-1s from covered benefits.
Source: Clinical Policy: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists (HIM.PA.53), policy HIM.PA.53. Read August 27, 2026.
The full Ambetter policy on Ozempic has the BMI bar, the step-therapy rule and what happens at renewal.
Does Ambetter cover Rybelsus?
Yes, with prior approval. Ambetter pays for Rybelsus once your prescriber gets the plan to sign off.
Ambetter marketplace plans cover Rybelsus for type 2 diabetes, but only with prior authorization. Rybelsus sits on Ambetter's preferred GLP-1 list, so the plan asks for a documented type 2 diabetes diagnosis, age 18 or older, no overlap with another GLP-1, and a dose within the FDA-approved maximum. Ambetter will not cover Rybelsus for weight loss, because Rybelsus is FDA-approved for type 2 diabetes only. Wegovy is the weight-loss semaglutide, and most Ambetter marketplace plans exclude weight-loss GLP-1s from covered benefits.
Source: Clinical Policy: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists (HIM.PA.53), policy HIM.PA.53. Read August 28, 2026.
The full Ambetter policy on Rybelsus has the BMI bar, the step-therapy rule and what happens at renewal.
Does Ambetter cover Mounjaro?
On some plans, yes. Ambetter publishes a different drug list for each plan it sells, so two people with the same insurer can get different answers.
Yes for type 2 diabetes, with prior authorization and step therapy, in the states where Mounjaro is on the plan's drug list. Some state formularies leave it off entirely. The Centene GLP-1 policy that governs Ambetter marketplace plans (CP.PMN.183) treats Mounjaro (tirzepatide) as a non-preferred agent, so approval needs a diagnosis of type 2 diabetes, an A1C at or above 7 percent after at least 3 months on metformin, and a documented failure of the plan's preferred GLP-1 drugs first. Ambetter will not cover Mounjaro for weight loss. Mounjaro is FDA-approved for type 2 diabetes only, and the tirzepatide approved for weight loss is Zepbound, which Ambetter marketplace plans exclude outside California.
Source: Centene Clinical Policy: Tirzepatide (Zepbound), Reference Number CP.PMN.298, section I.B and II.B, read alongside the Mounjaro prescribing information (Lilly, January 2026) confirming a type 2 diabetes indication only, policy CP.PMN.298. Read August 27, 2026.
The full Ambetter policy on Mounjaro has the BMI bar, the step-therapy rule and what happens at renewal.
Every insurer we have read
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.